Newsfeeds - Spark Newswire

4 minute read

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Today, 1:05 PM

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.

ABNB

8 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:05 PM

On Thursday, 116 companies set new 52-week lows.

AHPI

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 1:05 PM

On Wednesday, 258 companies hit new 52-week lows.

ACB

1 minute read

Truist Securities Downgrades Harpoon Therapeutics to Hold, Announces $2 Price Target

By Benzinga Newsdesk

Today, 1:05 PM

Truist Securities analyst Asthika Goonewardene downgrades Harpoon Therapeutics (NASDAQ:HARP) from Buy to Hold and announces $2 price target.

HARP

5 minute read

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 1:05 PM

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

ACMR

5 minute read

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 1:05 PM

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

ACET

3 minute read

Crude Oil Rises Sharply; Adicet Bio Shares Plunge

By Lisa Levin

Today, 1:05 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday

ACET

4 minute read

Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket

By Lisa Levin

Today, 1:05 PM

Gainers

$APE

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 1:05 PM

Gainers HTG Molecular Diagnostics (NASDAQ:HTGM) stock moved upwards by 170.4% to $1.46 during Monday’s pre-market session. The market…

ACET

2 minute read

Harpoon Therapeutics Presented Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma at ASH 2022; Said 77% (10/13) Objective Response Rate Observed Across Highest Doses (12 and 24 mg)

By Charles Gross

Today, 1:05 PM

Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today presented updated interim data from its Phase 1 clinical trial evaluating single-agent HPN217 in relapsed/refractory multiple myeloma (RRMM) in a poster presentation at the 64th American Society of Hemato

HARP